Catamaran Corporation is an American company that provides pharmacy benefits management services.

According to the law firm press release, the case alleges that Catamaran and its directors are violating Section 14(a) of the Securities Exchange Act of 1934 by seeking approval of the Proposed Transaction by means of materially false and misleading disclosures as currently contained in a preliminary proxy statement.

On April 12, 2016, Plaintiff's motion to voluntarily dismiss this case was granted.